Pharmacokinetics Research Laboratories, Translational Research Unit, R&D Division, Kyowa Kirin Co. Ltd., 1188 Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8731, Japan.
Pharmacokinetics Research Laboratories, Translational Research Unit, R&D Division, Kyowa Kirin Co. Ltd., 1188 Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8731, Japan.
J Pharm Biomed Anal. 2020 Jul 15;186:113329. doi: 10.1016/j.jpba.2020.113329. Epub 2020 Apr 24.
Therapeutic monoclonal antibodies can potentially induce unwanted immune responses, resulting in the production of anti-drug antibodies (ADAs). The binding of ADAs to drugs and subsequent formation of immune complexes (ICs) can trigger various responses, dependent on the size, concentration, and subclass of ADAs. To better understand the impact of ADAs on pharmacokinetics, pharmacodynamics, and toxicological profiles, a bioanalytical method was developed for the detection of ICs between human monoclonal immunoglobulin G (IgG) and ADAs in biological samples. Regarding the experimental procedure, in brief, the human antibody-specific ICs and unbound human antibody in biological samples are separated through blue native polyacrylamide gel electrophoresis (BN-PAGE). The target fractions are then cut from the gel, followed by in-gel trypsin digestion and subsequent liquid chromatography tandem-mass spectrometry (LC-MS/MS) to monitor the human IgG-specific peptide. This method was able to detect various types of human antibodies with a lower limit of detection of 10 μg/mL in monkey serum. The assay performance for the detection of ICs was demonstrated using spiked samples, and pre-incubated ICs in monkey serum were clearly detected. Taken together, these findings indicate that our method enables a semi-quantitative analysis for estimating the ratio of human antibody included ICs in comparison to the total antibody. This method was successfully applied to an in vivo study using mice, and the data helped explain the unexpectedly rapid clearance of a humanized antibody due to the formation of large ICs. The combination of the separation of ICs by BN-PAGE and the detection of the human IgG-specific peptide by LC-MS/MS is a useful general bioanalytical approach for the detection of ICs in animals.
治疗性单克隆抗体可能会引起不必要的免疫反应,导致产生抗药物抗体 (ADA)。ADA 与药物结合并随后形成免疫复合物 (IC) 会触发各种反应,这取决于 ADA 的大小、浓度和亚类。为了更好地了解 ADA 对药代动力学、药效学和毒理学特征的影响,开发了一种用于检测生物样品中人类单克隆免疫球蛋白 G (IgG) 与 ADA 之间 IC 的生物分析方法。关于实验程序,简而言之,通过蓝色 native 聚丙烯酰胺凝胶电泳 (BN-PAGE) 将生物样品中的人抗体特异性 IC 和未结合的人抗体分离。然后从凝胶中切下目标馏分,进行胶内胰蛋白酶消化,随后进行液相色谱串联质谱 (LC-MS/MS) 以监测人 IgG 特异性肽。该方法能够检测各种类型的人抗体,在猴血清中的检测下限为 10μg/mL。使用加标样品证明了检测 IC 的分析性能,并且可以清楚地检测到在猴血清中预先孵育的 IC。总之,这些发现表明,我们的方法能够对半定量分析来估计与总抗体相比包含在 IC 中的人抗体的比例。该方法已成功应用于使用小鼠的体内研究,数据有助于解释由于形成大 IC,一种人源化抗体出乎意料地快速清除的原因。BN-PAGE 分离 IC 与 LC-MS/MS 检测人 IgG 特异性肽的结合是一种用于检测动物中 IC 的有用的通用生物分析方法。